Topic
Article III Standing
144 published works
Patents Post-Grant
Competitor Standing to Evolve for PTAB Appeals?
By Scott McKeown, Scott McKeown Wolf Greenfield
Article III Review of Agency Action May Once Again Interest SCOTUS A perceived lack of Article III standing in appeals from the Patent Trial & Appeal Board (PTAB) to the Federal Circuit can doom…
PTAB Law Blog
Article III Standing for an IPR Appeal Despite Patent Expiration and No Pending Litigation
Article III standing has become a contested and often dispositive issue in appeals from the Patent Trial and Appeal Board (PTAB). For example, as we reported previously, the Federal Circuit…
Class Action Lawsuit Defense
Standing in Uncertainty: <i>Spokeo</i> Three Years Later
By Ken Prabucki, Brittany Lockyer
In 2016, the Supreme Court issued its decision in Spokeo Inc. v. Robins, holding that even when Congress has granted parties a statutory right, a procedural violation of that right…
Patents Post-Grant
Finality Aspect of Common Law Estoppel May Not Matter for PTAB Estoppel Under 315(e)
By Scott McKeown, Scott McKeown Wolf Greenfield
Standing Dispute Highlights 315(e)(2) Estoppel Concern Article III standing has been a problem for certain petitioners seeking review of adverse Patent Trial & Appeal Board (PTAB) AIA trial rulings. This…
Consumer Class Defense Counsel
Supreme Court Sidesteps Class Settlement Issue to Remand, Questioning Article III Standing Under Spokeo
By Jennifer M. Keas, Kathryn A. Shoemaker
On March 20, 2019, in Frank v. Gaos, 586 U.S. ___ (2019), the United States Supreme Court sidestepped a novel question regarding a cy pres class action settlement, instead remanding…
Consumer Class Defense Blog
Eighth Circuit Alert: District Courts Must Determine Article III Standing Before Approving Class Settlements
By Esther Slater McDonald, Tonya M. Esposito, Jonathan Huie
On January 8, 2019, Judge Grasz, writing for an Eighth Circuit panel, reiterated the need for district courts to determine Article III standing before approving class settlements. The appeal stemmed…
Patents Post-Grant
BPCIA & FDA Steps as Article III Standing from the PTAB?
By Scott McKeown, Scott McKeown Wolf Greenfield
Are Biosimilar Development Efforts Enough? In Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Co. (here), the Federal Circuit was poised to explore the level of biosimilar legwork that could satisfy Article III…
Cleary Cybersecurity and Privacy Watch
Fourth Circuit and Eighth Circuit Address Injury in Data Breach Cases
By Miranda Gonzalez, Roger A. Cooper
The nature of any injury suffered by individuals from a cyber incident continues to be a major issue in data breach litigation. As we have previously discussed, the Supreme Court…
Cleary Cybersecurity and Privacy Watch
Seventh Circuit Expands Jurisprudence in Data Breach Cases
By Rahul Mukhi, Alanna B. Newman, Roger A. Cooper
On April 11, 2018, the Seventh Circuit reversed a district court’s dismissal, for failure to state a claim, of plaintiffs’ proposed class action arising out of a 2012 data breach…
Hunton Retail Law Resource
Ninth Circuit Reverses District Court Decision in Zappos Consumer Data Breach Case
On March 8, 2018, the Ninth Circuit Court of Appeals reversed a decision from the United States District Court for the District of Nevada.